Himension Capital Singapore PTE. LTD. Cuts Stock Position in Lam Research Corporation $LRCX

Himension Capital Singapore PTE. LTD. decreased its holdings in Lam Research Corporation (NASDAQ:LRCX) by 20.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 86,051 shares of the semiconductor company’s stock after selling 21,880 shares during the quarter. Lam Research accounts for about 0.7% of Himension Capital Singapore PTE. LTD.’s holdings, making the stock its 21st biggest holding. Himension Capital Singapore PTE. LTD.’s holdings in Lam Research were worth $8,376,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in LRCX. Sava Infond d.o.o. increased its stake in shares of Lam Research by 3.1% during the second quarter. Sava Infond d.o.o. now owns 75,250 shares of the semiconductor company’s stock worth $7,325,000 after buying an additional 2,250 shares during the period. Empowered Funds LLC grew its holdings in Lam Research by 10.5% during the 1st quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock worth $13,629,000 after acquiring an additional 17,833 shares in the last quarter. Genus Capital Management Inc. purchased a new stake in shares of Lam Research in the 2nd quarter valued at approximately $14,476,000. Cookson Peirce & Co. Inc. purchased a new stake in shares of Lam Research in the 1st quarter valued at approximately $607,000. Finally, Glass Wealth Management Co LLC raised its holdings in shares of Lam Research by 8.5% in the 2nd quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock valued at $2,810,000 after purchasing an additional 2,270 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

Analysts Set New Price Targets

LRCX has been the subject of a number of analyst reports. Berenberg Bank boosted their target price on shares of Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. JPMorgan Chase & Co. lifted their price target on Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a report on Thursday, October 23rd. Weiss Ratings reiterated a “buy (b)” rating on shares of Lam Research in a report on Monday. Barclays set a $142.00 target price on Lam Research and gave the stock an “equal weight” rating in a research report on Monday, October 20th. Finally, Susquehanna boosted their target price on Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research note on Thursday, October 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus price target of $152.17.

Lam Research Trading Up 1.0%

NASDAQ:LRCX opened at $151.93 on Wednesday. The company has a market capitalization of $190.83 billion, a PE ratio of 33.46, a P/E/G ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $167.15. The stock’s 50 day moving average price is $145.43 and its 200 day moving average price is $113.50. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm’s revenue for the quarter was up 27.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, research analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is presently 22.91%.

Insider Buying and Selling at Lam Research

In other news, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the sale, the senior vice president owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 102,608 shares of company stock valued at $14,916,496. Company insiders own 0.31% of the company’s stock.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.